162 related articles for article (PubMed ID: 30608614)
1. Responsiveness of clinical and ultrasound outcome measures in musculoskeletal systemic lupus erythematosus.
Mahmoud K; Zayat AS; Yusof Y; Hensor E; Conaghan PG; Emery P; Vital EM
Rheumatology (Oxford); 2019 Jan; 58(8):1353-60. PubMed ID: 30608614
[TBL] [Abstract][Full Text] [Related]
2. Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures.
Thanou A; James JA; Arriens C; Aberle T; Chakravarty E; Rawdon J; Stavrakis S; Merrill JT; Askanase A
Lupus Sci Med; 2019; 6(1):e000365. PubMed ID: 31921432
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound to identify systemic lupus erythematosus patients with musculoskeletal symptoms who respond best to therapy: the US Evaluation For mUsculoskeletal Lupus longitudinal multicentre study.
Mahmoud K; Zayat AS; Yusof MYM; Dutton K; Teh LS; Yee CS; D'Cruz D; Ng N; Isenberg D; Ciurtin C; Conaghan PG; Emery P; Edwards CJ; Hensor EMA; Vital EM
Rheumatology (Oxford); 2021 Nov; 60(11):5194-5204. PubMed ID: 33792659
[TBL] [Abstract][Full Text] [Related]
4. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
Loncharich MF; Anderson CW
ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
[TBL] [Abstract][Full Text] [Related]
5. Defining inflammatory musculoskeletal manifestations in systemic lupus erythematosus.
Zayat AS; Mahmoud K; Md Yusof MY; Mukherjee S; D'Agostino MA; Hensor EMA; Wakefield RJ; Conaghan PG; Edwards CJ; Emery P; Vital EM
Rheumatology (Oxford); 2019 Feb; 58(2):304-312. PubMed ID: 30265343
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of anifrolumab across organ domains in patients with moderate-to-severe systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP-1 and TULIP-2 trials.
Morand EF; Furie RA; Bruce IN; Vital EM; Dall'Era M; Maho E; Pineda L; Tummala R
Lancet Rheumatol; 2022 Apr; 4(4):e282-e292. PubMed ID: 38288923
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Responsiveness of British Isles Lupus Assessment Group 2004 Index, Systemic Lupus Erythematosus Disease Activity Index 2000, and British Isles Lupus Assessment Group 2004 Systems Tally.
Yee CS; Gordon C; Isenberg DA; Griffiths B; Teh LS; Bruce IN; Ahmad Y; Rahman A; Prabu A; Akil M; McHugh N; Edwards CJ; D'Cruz D; Khamashta MA; Farewell VT
Arthritis Care Res (Hoboken); 2022 Oct; 74(10):1623-1630. PubMed ID: 33787088
[TBL] [Abstract][Full Text] [Related]
8. Performance of systemic lupus erythematosus responder index for detecting clinician-rated responders in patients with active systemic lupus erythematosus.
Leosuthamas P; Narongroeknawin P; Chaiamnuay S; Asavatanabodee P; Pakchotanon R
Int J Rheum Dis; 2023 Apr; 26(4):667-672. PubMed ID: 36802112
[TBL] [Abstract][Full Text] [Related]
9. Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index.
Kalunian KC; Urowitz MB; Isenberg D; Merrill JT; Petri M; Furie RA; Morgan-Cox MA; Taha R; Watts S; Silk M; Linnik MD
Rheumatology (Oxford); 2018 Jan; 57(1):125-133. PubMed ID: 29045736
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
Ward MM; Marx AS; Barry NN
J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
[TBL] [Abstract][Full Text] [Related]
11. Changes in quality of life in relation to disease activity in systemic lupus erythematosus: post-hoc analysis of the BLISS-52 Trial.
Jolly M; Annapureddy N; Arnaud L; Devilliers H
Lupus; 2019 Dec; 28(14):1628-1639. PubMed ID: 31674267
[TBL] [Abstract][Full Text] [Related]
12. Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics group.
Wollaston SJ; Farewell VT; Isenberg DA; Gordon C; Merrill JT; Petri MA; Kalunian KC;
J Rheumatol; 2004 Dec; 31(12):2390-4. PubMed ID: 15570639
[TBL] [Abstract][Full Text] [Related]
13. Plasma IL-6 levels correlate with clinical and ultrasound measures of arthritis in patients with systemic lupus erythematosus.
Ball EM; Gibson DS; Bell AL; Rooney MR
Lupus; 2014; 23(1):46-56. PubMed ID: 24243775
[TBL] [Abstract][Full Text] [Related]
14. Brief Report: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis.
Cheng LE; Amoura Z; Cheah B; Hiepe F; Sullivan BA; Zhou L; Arnold GE; Tsuji WH; Merrill JT; Chung JB
Arthritis Rheumatol; 2018 Jul; 70(7):1071-1076. PubMed ID: 29513931
[TBL] [Abstract][Full Text] [Related]
15. The lupus impact tracker is responsive to changes in clinical activity measured by the systemic lupus erythematosus responder index.
Devilliers H; Bonithon-Kopp C; Jolly M
Lupus; 2017 Apr; 26(4):396-402. PubMed ID: 27587460
[TBL] [Abstract][Full Text] [Related]
16. Psychometric properties of FACIT-Fatigue in systemic lupus erythematosus: a pooled analysis of three phase 3 randomised, double-blind, parallel-group controlled studies (BLISS-SC, BLISS-52, BLISS-76).
Rendas-Baum R; Baranwal N; Joshi AV; Park J; Kosinski M
J Patient Rep Outcomes; 2021 Apr; 5(1):33. PubMed ID: 33830377
[TBL] [Abstract][Full Text] [Related]
17. Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials.
Touma Z; Gladman DD; Ibañez D; Taghavi-Zadeh S; Urowitz MB
J Rheumatol; 2011 Nov; 38(11):2395-9. PubMed ID: 21885488
[TBL] [Abstract][Full Text] [Related]
18. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.
American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria
Arthritis Rheum; 2004 Nov; 50(11):3418-26. PubMed ID: 15529383
[TBL] [Abstract][Full Text] [Related]
19. Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials.
Manzi S; Sánchez-Guerrero J; Merrill JT; Furie R; Gladman D; Navarra SV; Ginzler EM; D'Cruz DP; Doria A; Cooper S; Zhong ZJ; Hough D; Freimuth W; Petri MA;
Ann Rheum Dis; 2012 Nov; 71(11):1833-8. PubMed ID: 22550315
[TBL] [Abstract][Full Text] [Related]
20. Ultrasonography and detection of subclinical joints and tendons involvements in Systemic Lupus erythematosus (SLE) patients: A cross-sectional multicenter study.
Salliot C; Denis A; Dernis E; Andre V; Perdriger A; Albert JD; Mammou Mraghni S; Griffoul-Espitalier I; Hamidou M; Le Goff B; Joulin SJ; Marhadour T; Richez C; Poursac N; Lazaro E; Rist S; Corondan A; Quinten C; Martaillé V; Valéry A; Ducourau E
Joint Bone Spine; 2018 Dec; 85(6):741-745. PubMed ID: 29454670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
